XML 81 R64.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Collaborative Agreements (Details) $ in Thousands | 1 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | ---
Nov. 30, 2013 USD ($) item | Dec. 31, 2016 USD ($) | Dec. 31, 2014 USD ($)
Collaborative Agreements |  |  |
Research revenue for work performed under cost sharing arrangement |  |  | $ 1,224
GSK | Revised Agreement |  |  |
Collaborative Agreements |  |  |
Upfront payment received | $ 0 |  |
Potential milestone payments upon achievement of post-approval and sales-based milestones | $ 40,000 |  |
Number of major markets outside the U.S. from whom parties to contractual arrangement is eligible to receive post-approval and sales-based milestones | item | 8 |  |
Milestone revenue recognized |  | $ 500 |
Biogen Idec |  |  |
Collaborative Agreements |  |  |
Research revenue for work performed under cost sharing arrangement |  |  | $ 1,200

X
- Definition Represents the amount of potential payments upon achievement of post-approval and sales-based milestones. + References No definition available. + Details
Name: | fold_CollaborativeArrangementAchievementOfPostApprovalAndSalesBasedMilestonesPotentialPayments
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents information pertaining to the number of major markets outside the U.S. from whom parties to contractual arrangement is eligible to receive post-approval and sales-based milestones. + References No definition available. + Details
Name: | fold_NumberOfMajorMarketsOutsideUnitedStatesFromWhomPartiesToContractualArrangementIsEligibleToReceivePostApprovalAndSalesBasedMilestones
Namespace Prefix: | fold_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents reimbursements for research and development costs under collaboration agreements. + References No definition available. + Details
Name: | fold_ResearchRevenue
Namespace Prefix: | fold_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Cash received from licensees for license fees during the current period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585 + Details
Name: | us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=51671726&loc=SL6892177-166501 + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=fold_GlaxoSmithKlinePLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=fold_RevisedCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=fold_BiogenIdecMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |